The importance of intensive care unit (ICU)–specific antibiograms has not been well established but may have key patient care implications if resistance rates are significantly different between the institution and a specific ICU location. Here, we argue that institutions should investigate and develop ultra-localized antibiograms for each ICU, especially for multi-drug resistant organisms.
Centers for Disease Control and Prevention. MDR Pseudomonas aeruginosa Antibiotic Resistance Data (2011-2014). Atlanta, GA. Date unknown. https://gis.cdc.gov/grasp/PSA/MapView.html. Accessed June 22, 2018.
2.
BaxRBywaterRCornigliaGet al. Surveillance of antimicrobial resistance—what, how and whither?Clin Microbiol Infect. 2001;7:316-325.
3.
RhodesAEvansLEAlhazzaniWet al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;43:304-337.
4.
KalilACMeterskyMLKlompasMet al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61-e111.
5.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing (M100). 28th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
